10/2023

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

10/2023

Oct 25, 2023, 18:29 | Positive
Mariana Arnaut: The day you realize that the company you dreamed of building is real
Mariana Arnaut, Founder and CEO of The After Cancer, shared a post by The After…
Oct 25, 2023, 18:24 | Blog
Svetlana Nikic on Breast Cancer Awareness Month: Help me in extending the awareness!
Quoting Svetlana Nikic, Founder of Precision Oncology Consulting, on LinkedIn: ''Breast Cancer Awareness Month. Breast…
Oct 25, 2023, 18:20 | Blog
Angela Mastronuzzi: Our data strongly support the favourable therapeutic profile of PBT for the treatment of CNS germ cell tumors
Angela Mastronuzzi shared on LinkedIn: ''Our latest paper is out with Frontiers! "Unraveling the impact of…
Oct 25, 2023, 18:16 | Blog
Ulrika Årehed Kågström reflects on World Cancer Leaders' Summit 2023
Quoting Ulrika Årehed Kågström on LinkedIn: ''Just returned home from participating in the World Cancer…
Oct 25, 2023, 18:13 | Blog
Aradhana Sarin: Science + Finance = Innovation
Quoting Aradhana Sarin, Group CFO and Executive Director of AstraZeneca, on LinkedIn: ''Science + Finance =…
Oct 25, 2023, 18:09 | Blog
Joanna Dodkins: Very excited to be presenting work conducted at the National Prostate Cancer Audit
Joanna Dodkins, Clinical oncology registrar at Guy's Hospital, London, shared on her Twitter: "Very excited to…
Oct 25, 2023, 18:04 | Insight
Talha Badar: Moving immunotherapy upfront in B-cell ALL
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on Twitter:…
Oct 25, 2023, 17:57 | Insight
Tian Zhang: Discussed by Sandhu Shahneen — we should likely wait for PSA recurrence before salvage radiation
Tian Zhang recently shared on Twitter: "RADICALS-HD showed a definitive equivalence in survival for adjuvant…
Oct 25, 2023, 17:52 | Insight
Ilya Tsimafeyeu: Patients with metastatic renal cell carcinoma and high fibrinogen levels who received nivolumab had worse overall survival
Ilya Tsimafeyeu, Director at Bureau of Cancer Re­search Russia, shared on Facebook: "Our study: Patients…
Oct 25, 2023, 17:44 | Drugs
Nicolas Hubacz: Top Selling Pharmaceuticals of 2023
Nicolas Hubacz shared on LinkedIn: "Top Selling Pharmaceuticals of 2023. As the COVID-19 pandemic's grip…
All: 805 Posts: 141 - 150